Oral pemphigus vulgaris preceding cutaneous lesions: Recognition and diagnosis

Journal of the American Dental Association

Volumn 131, Issue 8, 2000, Pages 1156-1160

  Sirois, David ^a   Leigh, Janet E ^b   Sollecito, Thomas P ^c  

^a NEW YORK UNIVERSITY   (United States)

^b Louisiana Stt Univ Sch Dent Lib   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; AGED; ARTICLE; BLOOD; CORNEA ULCER; FEMALE; HUMAN; MALE; MIDDLE AGED; MOUTH DISEASE; MOUTH MUCOSA; MOUTH ULCER; PATHOLOGY; PEMPHIGUS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; AUTOANTIBODIES; AZATHIOPRINE; CORNEAL ULCER; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; MYCOPHENOLIC ACID; ORAL ULCER; PEMPHIGUS; PREDNISOLONE;

EID: 0034243242     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2000.0349     Document Type: Article

References (28)

1. Lever WF. Pemphigus and pemphigoid. Springfield, Ill.: Charles C. Thomas; 1965.
2. Fine JD. Management of acquired bullous skin diseases. N Engl J Med 1995; 333(22):1475-84.
3. Bastuji-Garin S, Souissi R, Blum L, et al. Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol 1995;104(2):302-5.
4. Kyriakis K, Tosca A, Lehou J, Hatzis J, Vareltzidis A, Sratigos J. A five-year retrospective study on pemphigus and pemphigoid. Australas J Dermatol 1989;30(1):33-6.
5. Shoda Y, Hashimoto K, Matsuoka Y, Yoshikawa K. A case of pemphigus in a six-year-old girl. J Dermatol 1991;18(3):175-7.
6. Kanwar AJ, Kaur S. Pemphigus in children. Int J Dermatol 1991;30(5):343-6.
7. Simon DG, Krutchkoff D, Kaslow RA, Zarbo R. Pemphigus in Hartford County, Connecticut, from 1972 to 1977. Arch Dermatol 1980;116(9):1035-7.
8. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976;112(7):962-70.
9. Eversole LR, Kenney EB, Sabes WR. Oral lesions as the initial sign in pemphigus vulgaris. Oral Surg Oral Med Oral Pathol 1972;33(3):354-61.
10. Lamey PJ, Rees TD, Binnie WH, Wright JM, Rankin KV, Simpson NB. Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy. Oral Surg Oral Med Oral Pathol 1992;74(1):54-7.
11. Robinson JC, Lozada-Nur F, Frieden I. Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84(4):349-55.
12. Pisanti S, Sharav Y, Kaufman E, Posner LN. Pemhigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol 1974;38(3):382-7.
13. Sirois DA, Fatahzadeh M, Roth R, Ettlin D. Diagnostic patterns and delays in pemphigus vulgaris: experience from 99 patients. Arch Dermatol (in press).
14. Korman NJ. Pemphigus. Dermatol Clin 1990;8(4):689-700.
15. Eversole LR. Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases. Oral Surg Oral Med Oral Pathol 1994;77(6):555-71.
16. Calvanico NJ, Robledo MA, Diaz LA. Immunopathology of pemphigus. J Autoimmun 1991;4(1):3-16.
17. Fitzpatrick RE, Newcomer VD. The correlation of disease activity and antibody titers in pemphigus. Arch Dermatol 1980;116(3): 285-90.
18. Siegel MA, Balciunas BA, Kelly M, Serio FG. Diagnosis and management of commonly occurring oral vesiculoerosive disorders. Cutis 1991;47(1):39-43.
19. Nisengard RJ, Neiders M. Desquamative lesions of the gingiva. J Periodontol 1981;52(9):500-10.
20. Meurer M, Millns JL, Rogers RS 3d, Jordan RE. Oral pemphigus vulgaris: a report often cases. Arch Dermatol 1977;113(11): 1520-4.
21. Mourellou O, Chaidemenos CG, Koussidou T, Kapetis E. The treatment of pemphigus vulgaris: experience with 48 patients seen over an 11-year period. Br J Dermatol 1995;133(1):83-7.
22. Lamey PJ, Rees TD, Binnie WH, Wright JM, Rankin KV, Simpson NB. Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy. Oral Surg Oral Med Oral Pathol 1992;74(1):54-7.
23. Mashkilleyson N, Mashkilleyson AL. Mucous membrane manifestations of pemphigus vulgaris: a 25-year survey of 185 patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin. Acta Derm Venereol 1988;68(5): 413-21.
24. Bystryn JC. Adjuvant therapy of pemphigus. Arch Dermatol 1984;120(7):941-51.
25. Chryssomallis F, Dimitriades A, Chaidemenos GC, Panagiotides D, Karakatsanis G. Steroid-pulse therapy in pemphigus vulgaris: long term follow up. Int J Dermatol 1995;34(6):438-42.
26. Aberer W, Wolff-Schreiner EC, Stingl G, Wolff K. Azathioprine in the treatment of pemphigus vulgaris: a long-term follow-up. J Am Acad Dermatol 1987;16:527-33.
27. Pandya AG, Sontheimer RD. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide. Arch Dermatol 1992; 128(12):1626-30.
28. Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 1999;135(1):54-61.